BoYen Therapeutics, Inc. (TPEX:7891)
Taiwan · Delayed Price · Currency is TWD 24.35
+0.05 (0.21%)
At close: Feb 11, 2026
BoYen Therapeutics Company Description
BoYen Therapeutics, Inc., through its own proprietary prodrug technology platform, engages in drug research and discovery.
The company’s products include BY-101, used for treating acute myeloid leukemia (AML), and BY-102 and BY-103, for the treatment of multiple sclerosis and acute hematologic malignancies.
The company was founded in 2010 and is headquartered in Taipei, Taiwan.
BoYen Therapeutics, Inc.
| Country | Taiwan |
| Founded | 2010 |
| Industry | Pharmaceutical Preparations |
Contact Details
Address: No. 333 Section 1 Taipei, 110208 Taiwan | |
| Phone | 886 2 2711 1327 |
| Website | boyentherapeutics.com |
Stock Details
| Ticker Symbol | 7891 |
| Exchange | Taipei Exchange |
| Reporting Currency | TWD |
| SIC Code | 2834 |